A retrospective study of first-generation or second-generation TKI therapy in Non small cell Lung Cancer patients
Latest Information Update: 06 Apr 2020
At a glance
- Drugs Afatinib (Primary) ; Erlotinib (Primary) ; Gefitinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 06 Apr 2020 New trial record